معرفی
Paul Leeson is a Professor of Cardiovascular Medicine at the University of Oxford and Head of the Oxford Cardiovascular Clinical Research Facility. He is a Consultant Cardiologist at the John Radcliffe Hospital, specializing in Cardiovascular Imaging and Hypertension Management. As a Fellow of Wolfson College, he leads the Preventive Cardiology Research Group, focusing on early detection and prevention of cardiovascular disease in young populations, particularly those with hypertension risks linked to preeclampsia or preterm birth. His work integrates artificial intelligence (AI) to enhance diagnostic tools like echocardiography and improve patient outcomes. He holds leadership roles in national initiatives, including the NIHR Clinical Research Network and UK Biobank Imaging Advisory Board.
Research priorities include novel biomarkers for early disease, clinical trials for cardiovascular prevention, and AI-driven innovations in imaging. Notable contributions include the POP-HT trial for postpartum blood pressure management and studies on exercise interventions in preterm-born adults. His collaborations span imaging and prevention networks, emphasizing translational research to bridge clinical practice and technological advancements.
Publications highlight advancements in AI diagnostics, hypertension management, and cardiovascular risk assessment. He actively participates in guideline development for cardiovascular prevention and hypertension, ensuring evidence-based practices. His work underscores a commitment to integrating cutting-edge technologies and rigorous clinical research to address cardiovascular health challenges.
